HF FOODS GRP INC.DL-,0001

HF Foods reported adjusted EPS of $0.12 in the second quarter (expectation $0.04) and record revenue of $323.8 million, up 2.8% year‑over‑year. Despite revenue growth, gross margin and adjusted EBITDA margin declined due to tariffs and higher fuel costs. The company is pursuing growth through seafood and expects to close the acquisition of Searay Foods by the end of August, which should improve margins. The stock rose 10.9% after hours to $1.73, while management is targeting a mid‑term adjusted EBITDA margin of 4.5–5%. » More on de.investing.com

The board of directors of HF Foods Group approved a shareholder rights plan ("poison pill") and a related amendment to the articles of incorporation. Shareholders will receive a dividend in the form of rights that become exercisable if 15% or more of the common stock is acquired without board approval and will enable holders to buy additional shares at a discount; the exercise price for the participating Series AA corresponds to $9.55 for one one‑thousandth. The rights expire on June 10, 2027, and may be redeemed by the company before a trigger for $0.001 per right. HF Foods also reported a strong first quarter 2026, with revenue and earnings above expectations. » More on de.investing.com

HF Foods reported Q3 revenue of $307 million, beating expectations, but missed on EPS at $0.08 versus a forecast of $0.09. Despite revenue growth, net loss and adjusted net income improved, and adjusted EBITDA rose significantly. The stock fell 1.26% to $2.38 after the announcement. For Q4 the company expects results similar to Q3; management highlights strategic investments and expansion but sees risks from tariffs and changing consumer behavior. » More on de.investing.com